Axxon agreed to invest up to BRL300m (~USD58m) to acquire a controlling stake in Brazilian food production company Alibra Ingredientes. (2A+ Alimentos) Fundada em 2000, a Alibra Ingredientes é uma…
-
-
IDB Invest provided a USD14m loan to Costa Rica’s pharmaceutical company Calox. The project’s objective are the acquisition of the company’s current manufacturing plant to make improvements in infrastructure and…
-
Advent International has invested USD430m in Brazil-based cross-border payment platform Ebanx. Advent invested through its Latin American Private Equity Fund (LAPEF), Global Private Equity (GPE), Advent Tech and Sunley House…
-
Patria’s Athena Saúde has acquired Brazilian Hospital das Clínicas in Alagoinhas for BRL137.1m. (Fusões & Aquisições) A Athena Saúde adquire 100% do Hospital das Clínicas de Alagoinhas, na Bahia, por…
-
Crescera Capital sold its remaining 25% stake in Brazil-based medical education group Afya to German-based media conglomerate Bertelsmann, achieving a full exit. With this transaction, Crescera will finish divesting its…
-
Kinea Investimentos exited health provider Centro Clínico Gaúcho (CCG) in a BRL1.06b sale to Notre Dame Intermédica. (Money Times) A NotreDame Intermédica (GNDI3) assinou contrato para a aquisição do Centro…
-
SoftBank, via its Latin America Fund, has committed to invest up to USD150m in Grupo Bursatil Mexicano (GBM), an investment brokerage platform in the Mexican stock Market. (TechCrunch) Grupo Bursátil…
-
IFC has committed USD100m to Cerberus Emerging Market Special Situations Fund. The vehicle, which is managed by Cerberus Capital Management, will invest in credit opportunities in emerging markets, primarily targeting…
-
Darby International Capital has invested in Peru-based healthcare operations provider IBT Health. Transaction details were not disclosed. (Press Release) Darby International Capital LLC (“Darby International”) announced that Darby Latin American…
-
ACON Investments, through its Latin America Opportunities Fund V, alongside DEG, FMO and Proparco, has acquired Vitalis Group, a manufacturer and wholesaler company of generic injectable pharmaceuticals with production facilities…